Clinical Trials Logo
  1. Home
  2. Eosinophilic Esophagitis (EoE)
  3. NCT03245840

Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Participants With Eosinophilic Esophagitis (EoE)

Eosinophilic Esophagitis (EoE) Clinical Trial

Official title:
A Phase 3, Multicenter, Open-label Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Subjects With Eosinophilic Esophagitis (EoE)

Clinical Trial Summary

This is a continuation study of Budesonide Oral Suspension (BOS) in adults and adolescents with Eosinophilic Esophagitis (EoE) who have completed participation in the SHP621-302 extension study. The purpose of this study is to see if BOS is safe and well tolerated over the long-term in adolescents and adults with EoE.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03245840
Study type Interventional
Source Takeda
Contact
Status Terminated
Phase Phase 3
Start date October 5, 2017
Completion date April 26, 2022
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04394351 - Study to Investigate the Efficacy and Safety of Dupilumab in Pediatric Patients With Active Eosinophilic Esophagitis (EoE) Phase 3
Completed NCT03581838 - Eating With Eosinophilic Esophagitis (EoE)
Completed NCT02778867 - SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet Study Phase 2/Phase 3
Completed NCT01642212 - OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension Phase 2
Completed NCT05485779 - SAD, MAD and Food Effect Evaluation of Safety, Tolerability, and PK of AQ280 in Healthy Subjects Phase 1
Recruiting NCT04626609 - Prostaglandin and Cannabinoid Receptors in EoE
Completed NCT00762073 - Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic Esophagitis Phase 2
Terminated NCT02058537 - Bethanechol for Eosinophilic Esophagitis Phase 2
Completed NCT02605837 - A Study in Adolescents and Adults With Eosinophilic Esophagitis (EoE) Measuring Histologic Response and Determine if Reduction in Dysphagia is Achieved Phase 3
Completed NCT02320981 - Mucosal Impedance in Pediatric Population N/A
Recruiting NCT06389994 - Esophageal String Test Monitoring to Monitor Eosinophilic Esophagitis During Oral Immunotherapy
Completed NCT02736409 - An Extension Study to Evaluate Maintenance of Efficacy and Long-term Treatment Effect of Oral Budesonide Suspension (OBS) in Adults and Adolescents With Eosinophilic Esophagitis (EoE) Phase 3